⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIAFW News
bioAffinity Technologies, Inc. Warrant
Form 8-K
sec.gov
BIAF
BIAFW
Form 8-K
sec.gov
BIAFW
BIAF
Form 8-K
sec.gov
BIAFW
BIAF
bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung
businesswire.com
BIAFW
BIAF
Form 8-K
sec.gov
BIAFW
BIAF
Form 8-K
sec.gov
BIAFW
BIAF
bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues
businesswire.com
BIAFW
BIAF
Form 8-K
sec.gov
BIAFW
BIAF
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells
businesswire.com
BIAFW
BIAF
Form 8-K
sec.gov
BIAF
BIAFW